Literature DB >> 14672941

Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes.

Nisar Ahmad1, Hans-J Gabius, Sabine André, Herbert Kaltner, Subramanian Sabesan, René Roy, Bingcan Liu, Frank Macaluso, C Fred Brewer.   

Abstract

Galectin-3 is unique among the galectin family of animal lectins in its biological activities and structure. Most members of the galectin family including galectin-1 possess apoptotic activities, whereas galectin-3 possesses anti-apoptotic activity. Galectin-3 is also the only chimera type galectin and consists of a nonlectin N-terminal domain and a C-terminal carbohydrate-binding domain. Recent sedimentation equilibrium and velocity studies show that murine galectin-3 is a monomer in the absence and presence of LacNAc, a monovalent sugar. However, quantitative precipitation studies in the present report indicate that galectin-3 precipitates as a pentamer with a series of divalent pentasaccharides with terminal LacNAc residues. Furthermore, the kinetics of precipitation are fast, on the order of seconds. This indicates that although the majority of galectin-3 in solution is a monomer, a rapid equilibrium exists between the monomer and a small percentage of pentamer. The latter, in turn, precipitates with the divalent oligosaccharides, resulting in rapid conversion of monomer to pentamer by mass action equilibria. Mixed quantitative precipitation experiments and electron microscopy suggest that galectin-3 forms heterogenous, disorganized cross-linking complexes with the multivalent carbohydrates. This contrasts with galectin-1 and many plant lectins that form homogeneous, organized cross-linked complexes. The results are discussed in terms of the biological properties of galectin-3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14672941     DOI: 10.1074/jbc.M312834200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  165 in total

1.  Mathematical modeling of K-Ras nanocluster formation on the plasma membrane.

Authors:  Tianhai Tian; Sarah J Plowman; Robert G Parton; Yoel Kloog; John F Hancock
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

Review 2.  Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation.

Authors:  Ani Grigorian; Haik Mkhikian; Michael Demetriou
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

3.  Cross-linking of glycosphingolipids at the plasma membrane: consequences for intracellular signaling and traffic.

Authors:  Tove Irene Klokk; Simona Kavaliauskiene; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2015-09-25       Impact factor: 9.261

4.  Preliminary X-ray crystallographic analysis of an engineered variant of human chimera-type galectin-3 with a shortened N-terminal domain.

Authors:  Andrea Flores-Ibarra; Federico M Ruiz; Sabine Vértesy; Sabine André; Hans-Joachim Gabius; Antonio Romero
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

5.  Towards functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster.

Authors:  Sven Saussez; Francois Lorfevre; Denis Nonclercq; Guy Laurent; Sabine André; Fabrice Journé; Robert Kiss; Gérard Toubeau; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2006-01-25       Impact factor: 4.304

6.  Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.

Authors:  Annick Lagana; Jacky G Goetz; Pam Cheung; Avraham Raz; James W Dennis; Ivan R Nabi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 7.  Glycobiology of the ocular surface: mucins and lectins.

Authors:  Pablo Argüeso
Journal:  Jpn J Ophthalmol       Date:  2013-01-17       Impact factor: 2.447

8.  Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain.

Authors:  Sean R Stowell; Connie M Arthur; Kristin A Slanina; John R Horton; David F Smith; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

Review 9.  Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Authors:  Penelope M Drake; Wonryeon Cho; Bensheng Li; Akraporn Prakobphol; Eric Johansen; N Leigh Anderson; Fred E Regnier; Bradford W Gibson; Susan J Fisher
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

10.  Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells.

Authors:  Cécile Boscher; Yu Zi Zheng; Ramya Lakshminarayan; Ludger Johannes; James W Dennis; Leonard J Foster; Ivan R Nabi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.